Nile Therapeutics inks deal with Medtronic for heart failure treatment - San Francisco Business Times PDF Print
San Francisco Business Times
Nile Therapeutics Inc. will work with medical device giant Medtronic Inc. on a peptide to treat heart failure and renal disease. Specific financial terms of the deal weren't disclosed, but Minneapolis-based Medtronic (NYSE: MDT) will fund and provide ...
Nile To Collaborate With Medtronic To Develop Cenderitide As Post-Acute Therapy RTT News
Nile Therapeutics to Collaborate with Medtronic on Clinical Development of

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.